Viewing Study NCT00189904


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2025-12-25 @ 7:01 PM
Study NCT ID: NCT00189904
Status: COMPLETED
Last Update Posted: 2012-09-28
First Post: 2005-09-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
Sponsor: Bavarian Nordic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module